The Annual ACG Chicago Healthcare M&A Conference brings even more thought leadership, deal making, relationship building and sector development than ever.

Leading off with the insightful groundwork of the Marwood Group, we then delve into the intricacies of the most dynamic healthcare sectors and the middle market impact on these. After a morning of razor focused content, Ed Hughes returns by popular demand to cut through the public relations and spin to provide an honest view of the market in 2012 and beyond. And all this sets up an afternoon of opportunity. DealSource* (one-on-one) deal making sessions rotate in the boardrooms while executives, advisors and key experts surface new deals and markets during the new Innovation Track. Firms represented on the panels include Baxter Ventures, Cain Brothers, Ide Management Group, Health Care Service Corp. (Blue Cross Blue Shield), Medsurant Holdings, Surgical Care Affiliates, United Healthcare, Zotec Partners, and others. Finally, the packed day is capped off with an evening reception attended by presenters, deal makers and attendees.

* Limited to Private Equity Firms and Investment Bankers. Please confirm your interest in participating with ACG Chicago. Only those pre-scheduled may participate in those sessions.

, Chief Executive Officer, Medsurant Holdings, LLC: Since 2009, Mr. Busby has been the CEO of Medsurant Holdings, LLC, one of the leading providers of intraoperative neuromonitoring services in the U.S. Mr. Busby has over 30 years of domestic and international experience in senior level management positions in the healthcare industry. He has been a CEO, COO, Board Member, management consultant, and entrepreneur. He has served as a consultant to a variety of healthcare clients domestically, as well as in Europe, the Middle East, and Asia. His management experience in healthcare ranges from multi-hospital systems and solo-hospitals to surgery centers, technology companies, imaging centers, rehab facilities, physician organizations and group practices. Mr. Busby was President of the Midwestern Division for HCA Healthcare Corporation. He had P&L responsibility for all operations within a three-state region encompassing Colorado, Arizona and Nebraska, and total revenue exceeding $1.5 billion. He expanded HCA’s presence in the Denver market from two hospitals to nine hospitals, growing the company’s market share from 9% to 36% in two years. Mr. Busby received his Master of Healthcare Administration degree from Baylor University and a Bachelor of Science in Biology from Arkansas State University.

is the Director of Strategy for Surgical Care Affiliates (SCA) an operator of 145 ambulatory surgery centers, surgical hospitals, and hospital surgery departments, with approximately 3,700 full-time teammates, 2,000 physician partners, and 21 health system partners in more than 30 states. SCA provides patient care and clinical outcomes to more than 2,000 surgical patients each day, and generates more than $1 billion in annual system-wide revenue. In his role at SCA, Kent is involved in developing the overall strategic direction of the organization, including developing inorganic and organic strategies around new lines of business.

Prior to joining SCA, Kent was a member of the Dell Corporate Development team and has over 10 years of Mergers and Acquisitions, Investment Banking, Venture Capital and Corporate Finance experience. Prior to the Dell, Inc. acquisition of Perot Systems, Kent was a member of the Perot Systems Corporate Development Group. Prior to joining Perot Systems, Kent worked for Challenger Capital Group a middle market merchant banking firm in Dallas focused on principal investing. Previously, Kent worked in the transaction services advisory group for KPMG where he led M&A due diligence and financial analysis for both strategic and financial buyers.

Earlier in his career, Kent worked in the investment banking division of Salomon Smith Barney/ Citigroup in New York. While at Salomon Smith Barney/ Citigroup, Kent provided financial and advisory services to the health care industry, focusing primarily on mergers and acquisitions, as well as, equity and financing transactions. Additionally, Kent has worked with Motorola Ventures, the venture capital arm of Motorola and in the corporate finance group of a small market cap health care services company.

back to top

Anthony Davis has been involved in principal investing and consulting since 1992. Prior to founding Linden LLC, he was a Partner with One Equity Partners (formerly FCEC). Mr. Davis was previously a strategy and operations management consultant with Cresap, McCormick and Paget in Chicago and Hong Kong. Mr. Davis currently serves on the boards of directors of Behavioral Centers of America and Drayer Physical Therapy Institute and was a board member of Focused Health Solutions and Ranir. Mr. Davis is a member of the Economic Club of Chicago and the Chicago Council on Global Affairs.

Mr. Davis holds a Bachelor of Arts with honors in Economics from Northwestern University and an MBA with honors from the University of Chicago Graduate School of Business, where he was a Rosett Scholar and serves as a guest lecturer on private equity.

back to top

is the Managing Director of Cain Brothers & Company LLC in New York. Ray joined Cain Brothers in early 2006 as an investment banker to lead the firm’s franchise in Healthcare Information Technology (HCIT) and Pharmaceutical Services. As a former sell-side equity research analyst, Ray has followed HCIT since 1994. During his career as an analyst, Ray worked primarily at Bear Stearns, where he was named to Institutional Investor’s Top-rated list in 5 of his last 6 years, including two number 1 rankings. In addition to HCIT, Ray’s research coverage included pharmaceutical outsourcing, pharmaceutical distribution and publicly-traded hospital companies. Prior to working on Wall Street, Ray worked for 5 years at a start-up company focused on energy efficient lighting products, where he held various positions ranging from Engineering Manager to National Sales Manager.

Ray grew up in Queens, NY and currently resides with his family in Westchester County. He received a BE from the Cooper Union in New York, NY; an MS in Engineering from Columbia University, and an MBA from The Wharton School of the University of Pennsylvania.

is an attorney and partner at Seyfarth Shaw, LLP in Chicago office. She is the co-chair of the firm’s Health Care Practice Group and vice-chair of the firm’s Corporate Department. Ms. Gordon concentrates her practice in general corporate law with a specialization in the financial and health care industries. She advises clients in the areas of general business transactions, finance and private equity, mergers and acquisitions, health care regulatory matters, compliance, and corporate governance. Ms. Gordon represents general corporate and health care clients, including health care providers, PPOs, long term care facilities, hospitals, surgical centers, physician associations, physician groups, pharmaceutical companies, medical device companies, and biotech companies. She also handles commercial and real estate finance transactions, syndications, loan acquisitions, and participations, particularly in the health care and pharmaceutical industry.

is a Shareholder in Greenberg Traurig, LLP, based in its Chicago office.  He focuses his practice on transactions, health care regulations and government relations. For health industry companies and investors, his experience as a senior official at the U.S. Department of Health and Human Services, combined with nearly twenty years of experience as a transactional attorney, allow him to provide unique and advantageous insights to his clients.

Previously, Eric served in the position of Deputy Secretary of the U.S. Department of Health and Human Services. He also served as Regulatory Policy Officer of HHS, overseeing the development and approval of all HHS, CMS and FDA regulations and significant guidances. He also previously served as Deputy General Counsel of the Department.

Eric has spoken widely and been published both in the United States and overseas on health-related topics, including Medicare and Medicaid reform, health law, medical device regulation, food safety, vaccines, quarantine, public health preparedness and pandemic influenza. He has also served as a U.S. representative to the World Health Organization.  He is a graduate of Harvard University and Columbia University Law School.

Jeffrey E. Huffman

, MD, M.P.H., is Professor of Health Enterprise Management and Management and Strategy in the Kellogg School of Management and Professor of Preventive Medicine in The Medical School, Northwestern University. He first came to Northwestern in 1977 as the founding Director of the University's Center for Health Services and Policy Research, now the Institute for Health Services Research and Policy Studies, and served as its Director for 18 years. A native of Boston, Dr. Hughes is a graduate of The Boston Latin School, Amherst College, Harvard Medical School and Columbia University School of Public Health. He trained originally in general surgery at the Columbia-Presbyterian Medical Center in the City of New York. Prior to coming to Northwestern, he was for seven and one half years associated with the National Bureau of Economic Research and the Mt. Sinai School of Medicine also in the City of New York.

Under Dr. Hughes' leadership, the Center for Health Services and Policy Research, a University wide entity with five programs of active interdisciplinary research, grew from its founding in 1977 to be one of the most highly regarded, University based health services research Centers in the United States. Its five programs included: Health Care Policy and Financing, Long Term Care, Organization Behavior in Health, the Multi Purpose Arthritis Center at Northwestern, and the Department of Veterans Affairs HSR&D Field Station in collaboration with the Edward A. Hines, Jr. VA Hospital.

Dr. Hughes is particularly interested in the elaboration of national health policy, in the efficient utilization of resources in the delivery of health care, and in the future directions of our health system. Within the Center, he was co director of the Program in Health Care Policy and Financing and was for five and one half years Principal Investigator of the HCFA "Policy Center" at Northwestern. He was also Special Advisor to the V.A. Field Station and for many years served as the Director of the Non-Biomedical Component of the Multipurpose Arthritis Center. Simultaneous with being Center Director, Dr. Hughes served for three years as the Director of the Program in Health Services Management in the Kellogg School. The Program was recently chosen by U.S. News and World Report as one of the two highest-ranking health management programs in the United States. Dr. Hughes is also the originator of Northwestern's Joint MD/MBA Program, one of the first programs of its kind in the United States. In addition, to the best of our knowledge, Dr. Hughes is the first physician to be a tenured professor in a School of Management in the U. S.

Dr. Hughes is one of the five co-founders of the Association for Health Services Research, a charter member of its Board of Directors, and served as its first Vice President. He has also served as a member of the Board of Directors of The Association of Teachers of Preventive Medicine. He was the founding Editor of "HMO/PPO Trends," is a member of the Editorial Advisory Board of "Medical Interface;" "Health Business Digest;" and Group Health News. He is the Editor of the book, Perspectives on Quality in American Health Care, published by McGraw-Hill. He was chosen by Faulkner and Gray's Health Information Center as a charter member of "The Health Care 500," now "The Health Care 1500," a directory of the most influential Americans in the field of health policy. He was also chosen as a charter member of the "Managed Care 1500." In October 1999, the Pharmaceutical Care Management Association awarded Dr. Hughes "The Latiolais Honor Medal," the highest honor in Managed Healthcare. He possesses a distinguished record of publications and is a consultant to numerous health care organizations.

is Senior Director of Corporate Transactions and Business Analysis at Health Care Service Corporation (HCSC), the fourth largest health insurer in the United States operating the Blue Cross Blue Shield health plans in Illinois, Texas, Oklahoma, and New Mexico. In this role, Craig is responsible for overseeing HCSC's mergers, acquisitions and joint ventures including business evaluation, valuation analyses, due-diligence, negotiations, and deal structuring and execution. Prior to joining HCSC, Craig worked for eight years in management consulting with Accenture and Deloitte Consulting, assisting health industry clients including HCSC, CareFirst BCBS, Bristol-Myers Squibb, and Kaiser Permanente.

Craig holds a B.A. in Political Science from Hope College and a Masters in Public Affairs from Indiana University's School of Public and Environmental Affairs.

is the Managing Director for the Marwood Group. Since joining the Marwood Group in 2007, Mr. Kelliher has been responsible for managing the day-to-day work product of the Marwood Research Group. Prior to joining Marwood, Mr. Kelliher was a Vice President at Timmons and Company, a Washington-based lobbying firm. Previous to that position, Mr. Kelliher served from 2001 to 2003 as Chief Counsel for the Committee on Ways and Means in the U.S. House of Representatives. As Chief Counsel, he was responsible for managing the legislative process for the Committee. Mr. Kelliher acted as a primary advisor to Chairman Bill Thomas on policy issues, political strategy and procedural tactics. During his tenure at the Committee on Ways & Means, significant legislation was enacted including the Medicare Modernization Act of 2003. Mr. Kelliher has also worked as Counsel and Chief Counsel at the Committee on House Administration. Mr. Kelliher received his undergraduate degree from Princeton University and then served three years of active duty in the U.S. Army. He graduated from the Boston University School of Law and holds the FINRA series 7, 24, 65, 86 and 87 securities licenses

is the President and Chief Executive Officer of Salter Labs. She has over 28 years of healthcare experience, serving in numerous executive positions in finance, strategy and marketing, and operations in corporate and line roles, as well as general management roles. Prior to joining Salter Labs, Ms. Kiernan spent a cumulative total of 22 years with Baxter Healthcare Corporation. Most recently, she was the General Manager for Baxter IV Therapy, a $1.5 billion global business unit.

After an initial 12 years with Baxter, primarily in the areas of finance and operations, in 1995 Ms. Kiernan joined Allegiance Healthcare Corporation as VP of Finance, Distribution, and Services. She returned to Baxter in 2000, in 2001 was appointed VP/GM, Specialty Therapies, and became GM, Baxter Nutrition in 2003.

Ms. Kiernan serves on the board of directors of the American Red Cross of Greater Chicago, and is a past-president of the Healthcare Businesswomen’s Association, Chicago Chapter. Until its recent sale, she also served on the board of directors of American Medical Systems (NASDAQ: AMMD), a Minneapolis-based medical device company.

Thomas S. Law is President and CEO of Zotec Partners. He helped form Zotec in May 1998. Prior to operating under the Zotec name, the company was Allmed Financial, Inc., a wholly owned subsidiary of Anthem. Allmed grew by acquisitions to be the third largest medical billing company in the nation. Law was the CFO/CIO responsible for migrating all of the 17 acquired practice management systems into one internally developed solution. He spent three years working with Andersen Consulting to develop the Electronic Billing Center (EBC) software suite. In 1998, when Anthem wanted out of the billing business, Law was able to divest Anthem of Allmed and purchase the EBC software. Thus, Zotec Solutions was formed in 1998.

In 2007, Zotec Solutions merged with Healthcare Management Partners to create Zotec Partners. Zotec Partners merged with Susan J. Taylor, Inc. in July 2007 and with EmPhysis Medical Management in September 2007. Four years later, Zotec Partners merged with Medical Business Service, Inc., one of Florida's largest and most respected medical billing companies.

As a proud graduate of Butler University, Law enjoys giving back to his alma mater and helping to pave the way for future business leaders. He is the Butler College of Business (COB) Zotec Entrepreneur Executive in Residence, and a Board of Visitor’s member. In 2012, the COB introduced the Zotec Business Competition for the Real Business Experience practicum. This competition provides a monetary incentive and mentorship from Zotec executives to help COB students create and manage a real business successfully.

---

Julie Sawyer Montgomery is Vice President, Global Marketing for Hospira’s Medication Management Systems business, a $600M global business including infusion pumps and sets, safety software, and services. She also serves as Vice President, Business Insights for all of Hospira’s businesses, across devices, pharmaceuticals, and biosimilars.

Prior to joining Hospira in 2010, Ms. Sawyer Montgomery served as Director, Marketing Strategy for Boston Scientific’s Cardiovascular division. Prior to her six years at Boston Scientific, Ms. Sawyer Montgomery served pharmaceutical and biotech clients as a project leader with Boston Consulting Group’s healthcare practice.

Ms. Sawyer Montgomery holds a B.A. magna cum laude in Economics from Columbia University and a MBA from Harvard Business School.

is Chief Executive Officer, Chairman of the Board and co-founder of Intelligent Medical Objects, Inc. He was also co-founder of Intelligent Medical Systems, Inc., which was bought by Glaxo in 1994, in addition to his expertise in electronic medical record systems and other entrepreneurial ventures. He has been nominated for special recognition by the Oracle Corporation Smithsonian Award in the category of Medicine. Dr. Naeymi-Rad is a member of numerous professional organizations, as well as author and co-author of numerous peer-reviewed publications and patents in the field of Medical Informatics. His degrees are from Southern Illinois University and the Illinois Institute of Technology, the latter a Ph.D. in Computer Science. His thesis work focused on the role of medical vocabulary to support data base translation, information retrieval, intelligent medical records, and expert systems.

---

Al B. Reid is currently Vice President of Corporate Development for Abbott Laboratories. Al joined Abbott in June 2000. Al provides the executive management team strategic advisory and operational support for Abbott’s pharmaceutical, medical device, diagnostic and nutrition businesses with combined revenue over $40 billion.

Mr. Reid has spent over 20 years leading a variety of healthcare initiatives for Abbott and Baxter including cross border transactions, strategic development and emerging market acceleration programs. During his career, Mr. Reid has worked in over 50 countries and has extensive experience executing multiple M&A transactions. Al’s previous professional experiences include Baxter Healthcare, Dun & Bradstreet, Paramount Communications and the Federal Reserve Bank where he held positions of increasing responsibilities in finance, business development and management consulting.

Mr. Reid is a member of the Executive Leadership Council, the Association of Corporate Growth, and the Chicago Foreign Council. Al serves on the board of several organizations, including the HistoryMakers, Chicago Youth Centers and Advocates USA. Mr. Reid is a frequent guest panelist discussing topics ranging from sustaining business growth to business expansion through emerging market activities.

---

Grant Riedinger is the Vice President, Solutions for Baxter Healthcare. Mr. Riedinger is a seasoned healthcare industry executive with over 20 years of professional experience in pharmaceuticals and medical devices. Grant has held a variety of global commercial and operational roles having worked at industry leading companies including GE Medical, Johnson and Johnson, Abbott Laboratories and most recently Baxter Healthcare.

At Baxter Healthcare, Grant has led global marketing for Infusion Systems, managed Baxter’s Consent Decree and been the General Manager the Global Pharmaceutical Injectable business. Most recently, Grant has taken on increased responsibility for Pharmaceutical Injectables, IV Solutions and Pharmacy devices which constitute a portfolio well over $2B in global sales.
Grant has a Bachelor of Science from Pennsylvania State University and an MBA from the University of Chicago.

In his spare time, Grant is a Soccer coach and serves on the Illinois Board of FIRST Robotics.

has practiced in SNR Denton's Corporate practice since 1990 and has significant experience in private equity and venture capital transactions, corporate mergers and acquisitions, joint venture formation, securities matters, corporate finance, and workouts and restructurings, as well as general corporate counseling. Michael is a member of SNR Denton's Venture Technology practice and its Private Equity practice.

Michael has significant experience representing technology and other companies in their capital-raising efforts and in general corporate matters. He is a member of the Illinois Venture Capital Association, where he serves on its Legislative Committee, and he speaks frequently on issues relating to venture capital and early-stage companies.

---

John Smolen is a Project Director at Northwestern Memorial HealthCare (NMHC), where he is responsible for technology strategy and planning. John started his career in healthcare technology with a B.S. in Electrical and Computer Engineering from University of Illinois at Urbana-Champaign, then worked as a software engineer at Motorola. After receiving his MBA with a concentration in Health Sector Management from Duke University, John worked as a management consultant at McKinsey & Company advising medical device and health plan clients on business strategy. In his role at NMHC, John defines and leads initiatives to support and enable NMHC’s overall business strategy with innovative technology solutions. John lives in Chicago with his wife and three children.

is a partner in Venable’s Legislative and Government Affairs group. As Congressman to Michigan’s First Congressional District for 18 years, Mr. Stupak developed a deep understanding of issues that directly affected his constituents, including matters related to energy, healthcare, telecommunications and international trade. As an attorney at Venable, he is in a unique position to provide clients with well-informed, extensive counsel that is based on a thorough knowledge of these industries and related legislation.

While in Congress, Mr. Stupak served on the Energy and Commerce Committee for 16 years. During his tenure on the Energy and Commerce Committee, he served on a number of subcommittees, including Health, Energy and the Environment, Communications, Technology and the Internet, Consumer Protection, Commerce and Trade, and Oversight and Investigations. As Chairman of the Oversight and Investigations Subcommittee, Mr. Stupak helped lead investigations into key issues, such as physical and cyber security breaches at U.S. nuclear labs, food and drug safety, and insurance company rescissions of insurance policies. He also played an important role in the passage of H.R. 3590, the Patient Protection and Affordable Care Act of 2010. Additionally, Mr. Stupak served on the Armed Services, Government Reform and Merchant Marine and Fisheries Committees.

Prior to joining the U.S. House of Representatives, Mr. Stupak worked in private practice in Michigan. Mr. Stupak began his career in public service as a police officer in Escanaba, Michigan. He continued his career in law enforcement as a Michigan State Police Trooper until he was medically retired due to an injury sustained in the line of duty. He also served in the Michigan House of Representatives.

In spring 2011, Mr. Stupak was a Fellow at the Institute of Politics, Harvard University, John F. Kennedy School of Government.

is Managing Director, Emerging Business of Aetna Inc. Drew leads M&A for Aetna’s Emerging Business (EB). EB is a group within Aetna responsible for building a portfolio of new businesses outside of Aetna’s core insurance products. EB leverages assets such as Medicity, ActiveHealth, iTriage and other recent acquisitions. EB also launches new businesses, such as Accountable Care Solutions, to address new market opportunities.

Prior to joining Aetna, Drew was a Managing Director at Sandbox Industries in Chicago. Drew managed the corporate venture fund Blue for Cross Blue Shield, nearly $300 million from 22 BCBS Plans focused on healthcare technology and innovation. Drew led investments in Bloom Health, ZeOmega, Change:Healthcare, Nexidia and InVivolink. Prior to joining Sandbox, Drew was a Vice President at Bank of America in New York. He worked in the Healthcare Mergers and Acquisitions group, and executed numerous healthcare services, life sciences, and medical device transactions. Drew was also a Strategy Consultant for USWeb / CKS and Manager of Strategy and Business Development for Fluid, a web development firm, both in San Francisco. Drew has a BA from Stanford University and a MBA from the Kellogg School of Management at Northwestern University.

is a recognized health care executive with more than 30 years of experience in the life sciences, managed care and specialty healthcare sectors. Mr. Velasquez’ areas of broad expertise includes organizational leadership, operations and strategic innovation. Mr. Velasquez is a managing partner with Tricium Health Partners, a leading Knowledge Process Outsourcer which specializes in providing clinical management solutions. Previously, Mr. Velasquez served as Chief Executive Officer for one of the country’s largest health care data management companies. He also held the role of Chief Executive Officer for Synarc, a global provider of specialized scientific services for the life sciences industry. Concurrent with his tenure at Synarc, Mr. Velasquez served as an Operating Partner with SV Life Sciences, a leading international life sciences venture capital firm. In addition, Mr. Velasquez has over 20 years of hands-on operating experience in leading and operating national health plan and indemnity insurance organizations.

joined Baxter in January, 2012 as Senior Managing Director - Baxter Ventures, the corporation’s $200 million venture fund. Prior to joining Baxter, she was a General Partner at Quaker Partners, where she spent the last 8.5 years leading investments in Biopharmaceutical and Healthcare companies and being integral part of the team in raising capital for the funds. Dr. Vemuri's role in building and mentoring portfolio companies has helped lead their exit through either acquisition or through Initial Public Offering. Some of her representative Quaker portfolio board member or observer responsibilities include Protez, Cempra, Corridor, Regado and Tranzyme Pharma.

Prior to Quaker, she was an Associate at Toucan Capital, where she was responsible for investments in seed-stage and start-up biotech opportunities. She participated in raising capital and helped start several portfolio companies by identifying technologies from universities. Prior to that, she was an Associate Equity Analyst at SalomonSmithBarney and First Union Securities covering specialty pharmaceuticals and healthcare sectors. Geeta was also a research scientist at The Wistar Institute and completed her postdoctoral fellow program at Thomas Jefferson University.

is the President and Chief Executive Officer of UnitedHealthcare of Illinois, an operating division of UnitedHealth Group and the largest single health carrier in the United States. (NYSE: UNH). UnitedHealthcare of Illinois serves over 1.2 million people in Illinois and contracts directly with over 22,500 physicians and 150 hospitals.

As a recognized leader in the health and well-being industry, we strive to:

• Help individuals access quality care at an affordable cost;
• Simplify health administration and delivery;
• Strengthen the physician/patient relationship;
• Promote evidence-based care; and
• Empower physicians, health care professionals, consumers, employers, and other participants in the health system with actionable data to make better, more informed decisions.

Tom has been with UnitedHealthcare since 1999 and served in a variety of finance and operating roles prior to his appointment as the President and CEO of UnitedHealthcare of Illinois in April 2007. Prior to UnitedHealthcare, Tom was a finance manager with Aetna and Prudential Health Care. He also worked at Bankers Trust in New York as a securities settlement analyst. His professional career began as an officer in the United States Marine Corps and served as a logistics officer and company commander.